PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression - Test2 - elhamkhani - TriplyDB

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

http://www.wikidata.org/entity/Q29618956

about

Tuberculosis and HIV co-infection HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses Emerging concepts in the immunopathogenesis of AIDS The protein LEM promotes CD8⁺ T cell immunity through effects on mitochondrial respiration Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications The PD-1 pathway in tolerance and autoimmunity Role of PD-1 in HIV pathogenesis and as target for therapy MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules Targeting the latent reservoir to achieve functional HIV cure Metabolism Is Central to Tolerogenic Dendritic Cell Function Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy Cytomegalovirus Infection and Memory T Cell Inflation Sepsis: From Pathophysiology to Individualized Patient Care Molecular and cellular insights into T cell exhaustion Enhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic Peptides Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck T-cell therapies for HIV NKT cell networks in the regulation of tumor immunity Immune regulation of human herpesviruses and its implications for human transplantation Developing Combined HIV Vaccine Strategies for a Functional Cure HIV therapeutic vaccines: moving towards a functional cure The immunological synapse: the gateway to the HIV reservoir Evaluation of current cancer immunotherapy: hemato-oncology HIV: inflammation and bone Herpesvirus exploitation of host immune inhibitory pathways CD8 T cell persistence in treated HIV infection T cell replicative senescence in human aging Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancer CD4 T-cell immunotherapy for chronic viral infections and cancer The enduring tale of T cells in HIV immunopathogenesis Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection

P2860

Q21131403-55A26776-09CD-4BEA-87E7-C7338BAF6BC7 Q22001527-7B483925-7D01-4ACA-A33C-6860C76FF124 Q22241984-96F077E7-C9DD-4E46-A359-FD8A6ED3E049 Q24336998-613973B3-6684-4750-8606-E4468DA8BB69 Q24564396-14CE5043-2D34-49E2-8B32-F3F999814E58 Q24600313-AB45B605-B1CA-4ABE-83AE-651474003D8D Q24607794-2B364D31-C724-4DC9-B482-636223B4B50C Q24633549-F7F4EFB3-7F5D-46EB-BC40-D62DA94D4742 Q24634293-EB15CE57-76F9-413D-B9AC-D595390B1DC6 Q24644382-9EEB651E-E63B-454E-92B0-97AA27A884C4 Q24652185-8B80945C-6149-45EF-BBCE-381073791301 Q24685406-931F64DF-1744-490B-BBAC-E6E4A3E649F8 Q26744626-7482A956-F006-48EA-8688-1C4FA4A276B9 Q26744635-0EF0EA90-47CD-4018-A258-F32008AE6D29 Q26745923-396E068A-3D02-4050-8AC1-01C63586F96B Q26765348-0D5BFE7D-2BFD-4523-A8B9-8A848271BE81 Q26773283-80BCC72A-8D15-4A78-B821-53A52E5E65DF Q26781481-E43C40BA-510D-4C21-BCDF-BCF826AEBFB1 Q26786776-DEAC8ECF-B192-48A9-98A3-D9E0316AACEE Q26799911-21A54043-1181-416F-A8FD-B4C766111175 Q26800047-74F205A6-F4E3-450B-B2BA-3803D36E2F68 Q26800123-EBBB5F2E-0FB4-4F71-8BDA-BD5F7427E3DC Q26827712-C3BF390D-5D6E-4022-B515-4F0BA5D2CD7F Q26828598-5941292E-97D5-43F3-8501-4928E39A6A8A Q26866079-476C1DB9-5050-4042-ACD0-558AB20F67EC Q26866223-1EFA6195-1EF0-4231-A4FE-EBE4228021FB Q26992146-77496F82-4272-461F-8E64-6BC53A50632D Q26998898-8F7E5C1D-1ABC-43EE-9093-0CAF5920B42A Q27002180-9BD2D732-F1FC-4356-94EE-D284A12830FB Q27002959-C6A17B19-BEA7-495D-B60F-7D65FD4BEE77 Q27006179-5F040953-3FE9-4E57-964C-BF42D1A83385 Q27010898-251699BF-A746-43D2-BCF7-DE139A583359 Q27013680-AE1D3D9E-1646-4D4A-A875-E4724BE13323 Q27014768-17B380C4-0B53-4A34-A79D-59248403E54F Q27022690-0248D6E6-11C3-4ED5-9BB0-A55D12B58242 Q27022761-013CDE99-9C62-46D6-B903-8733C2F0E1B9 Q27022957-33A56954-8FE6-4F07-9716-EB20010FEC40 Q27025707-39FD6ACE-9F74-46C5-8D79-48D83D5962AD Q27314913-2582B7CD-543B-4203-A9EB-D869FDC7B8E0 Q27316403-8BCFC66A-5D16-4FBE-BD6A-93A082D0E1C0

P2860

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

http://www.wikidata.org/entity/Q29618956

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

PD-1 expression on HIV-specifi ...... ustion and disease progression

@ast

PD-1 expression on HIV-specifi ...... ustion and disease progression

@en

type

label

PD-1 expression on HIV-specifi ...... ustion and disease progression

@ast

PD-1 expression on HIV-specifi ...... ustion and disease progression

@en

prefLabel

PD-1 expression on HIV-specifi ...... ustion and disease progression

@ast

PD-1 expression on HIV-specifi ...... ustion and disease progression

@en

P1433

Q29618956-5BAC08A0-8706-4DFA-8904-0A701B55ED20

P1476

Q29618956-B1B6B931-BEF3-406D-8DD4-939F755F1D17

P2093

Q29618956-138EA2D4-4FE4-44B1-B14A-2F009E7B95B1

Q29618956-1A2A2C30-BD2E-4432-B8BF-47E5574597D7

Q29618956-1C01BF3C-FEF1-4BF2-A25F-B9882F7403AC

Q29618956-1C469F2C-5069-48BF-A10B-E1FD5F617627

Q29618956-2D2CD3CC-4951-4E74-8EBC-03959F49A093

Q29618956-358A123C-7AA6-46B5-AA33-6EA22867569C

Q29618956-50B1442B-6ED6-469D-AED7-92FF0E2C69C5

Q29618956-55FA1317-E66A-4FCE-A01B-A4082D628497

Q29618956-61AB0B38-2038-4CE8-B86C-9DBED766EB9C

Q29618956-68BC74DF-11B2-430D-9D60-330CE9C44BE4

P2860

Q29618956-185D4EF6-848E-44F1-8931-B7440B81A75E

Q29618956-21F59787-179D-44DA-8AF1-8B7BA92B1434

Q29618956-24DD63B9-D7DA-4216-A70F-EF6D10CF281E

Q29618956-27B8E21C-E08C-4230-B529-700589417276

Q29618956-286B1485-5DF5-46E7-8780-262BCB2E7149

Q29618956-3CE8B895-A9A4-4BC2-BB44-B578938CD961

Q29618956-5836C2B5-D536-48C9-9B50-441A749FB4A3

Q29618956-67087C8D-C59E-49A3-ACFD-90D522D3FD8E

Q29618956-6AB92E35-2CF0-4DF2-871D-CCD2506B2AA6

Q29618956-72507198-FF44-4051-A58C-0C316C6A701A

P2888

Q29618956-9A20DB2D-2D8D-48DB-823C-DFA5495AFDB4

P304

Q29618956-DBA0891A-3CD9-4B8E-822D-D3A6F8DA161B

P31

Q29618956-0CDA92EA-050A-4C60-80D7-FCB07690DDDD

P3181

Q29618956-B68C3C64-7800-43FF-85D2-56AEF103C097

P356

Q29618956-0FDCF428-7B62-4928-89A8-F008687DA1CF

P407

Q29618956-196D0B28-364D-4858-8AEE-3BD62FB25587

P433

Q29618956-BFEC00AD-FA62-4F1E-8828-8725E85BFD93

P478

Q29618956-363CC16A-923C-4595-8687-8C49A0519800

P50

Q29618956-5A50A251-83AD-4905-8BA3-AE6F28E360EB

Q29618956-93A8A788-6B15-4EC0-96A2-03822C07AF8F

P577

Q29618956-F4AE973F-EA4D-497B-ADB8-0C09B08F9F2E

P5875

Q29618956-E46AD907-3CD9-40D6-BCCA-62F6BA4BA24A

P6179

Q29618956-EEBD465E-4228-4F20-A342-CE246009F13F

P698

Q29618956-A4E37C69-4DCE-4CDD-9DA5-7D2714082D6F

P3181

P356

P1433

P1476

PD-1 expression on HIV-specifi ...... ustion and disease progression

@en

P2093

Baogong Zhu

http://www.w3.org/2001/XMLSchema#string

Bruce D Walker

http://www.w3.org/2001/XMLSchema#string

Chantal DePierres

http://www.w3.org/2001/XMLSchema#string

Cheryl L Day

http://www.w3.org/2001/XMLSchema#string

Daniel E Kaufmann

http://www.w3.org/2001/XMLSchema#string

E John Wherry

http://www.w3.org/2001/XMLSchema#string

Elizabeth W Mackey

http://www.w3.org/2001/XMLSchema#string

Eshia S Moodley

http://www.w3.org/2001/XMLSchema#string

Gordon J Freeman

http://www.w3.org/2001/XMLSchema#string

Hoosen M Coovadia

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Restoring function in exhausted CD8 T cells during chronic viral infection

Phenotypic analysis of antigen-specific T lymphocytes

A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay.

Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.

The B7-CD28 superfamily.

P2888

P304

350-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

326750

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE05115

http://www.w3.org/2001/XMLSchema#string

P407

P433

7109

http://www.w3.org/2001/XMLSchema#string

P478

443

http://www.w3.org/2001/XMLSchema#string

P50

Alasdair Leslie

P577

2006-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6867578

http://www.w3.org/2001/XMLSchema#string

P6179

1050830005

http://www.w3.org/2001/XMLSchema#string

P698

16921384

http://www.w3.org/2001/XMLSchema#string